UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups

Annals of oncology, 2009-10, Vol.20 (10), p.1653-1659

2009

Volltextzugriff (PDF)

What Would You Do? Specialists’ Perspectives on Cancer Genetic Testing, Prophylactic Surgery, and Insurance Discrimination

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2484-2492

2000

Volltextzugriff (PDF)

Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women

Journal of medical genetics, 2006-02, Vol.43 (2), p.133-137

2006

Volltextzugriff (PDF)

Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

Journal of clinical oncology, 2004-03, Vol.22 (6), p.1055-1062

2004

Volltextzugriff (PDF)

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7804-7810

2005

Volltextzugriff (PDF)

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

The lancet oncology, 2006-03, Vol.7 (3), p.223-229

2006

Volltextzugriff (PDF)

Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

The New England journal of medicine, 2002-05, Vol.346 (21), p.1616-1622

2002

Volltextzugriff (PDF)

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

The Lancet (British edition), 2002-04, Vol.359 (9316), p.1471-1477

2002

Volltextzugriff (PDF)

Germline PTEN Promoter Mutations and Deletions in Cowden/Bannayan-Riley-Ruvalcaba Syndrome Result in Aberrant PTEN Protein and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway

American journal of human genetics, 2003-08, Vol.73 (2), p.404-411

2003

Volltextzugriff (PDF)

Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ

JAMA : the journal of the American Medical Association, 2005-02, Vol.293 (8), p.964

2005

Volltextzugriff (PDF)

The breast surgeon’s role in BRCA1 and BRCA2 testing

The American journal of surgery, 2000-10, Vol.180 (4), p.294-298

Matloff, Ellen T

2000

Volltextzugriff (PDF)

Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history

The cancer journal from Scientific American, 1998-09, Vol.4 (5), p.302

1998

Volltextzugriff (PDF)

BRCA1/BRCA2 Germline Mutations in Locally Recurrent Breast Cancer Patients After Lumpectomy and Radiation Therapy: Implications for Breast-Conserving Management in Patients With BRCA1/BRCA2 Mutations

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3017-3024

1999

Volltextzugriff (PDF)

Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer?

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1501-1501

2011

Volltextzugriff (PDF)

Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer

Breast cancer research : BCR, 2005-01, Vol.7 (6), p.R1017-R1022, Article R1017

2005

Volltextzugriff (PDF)

Complex decision-making for BRCA1/2 carriers

The cancer journal from Scientific American, 1999-09, Vol.5 (5), p.266

Matloff, E T

1999

Volltextzugriff (PDF)

Writing Effective Insurance Justification Letters for Cancer Genetic Testing: A Streamlined Approach

Journal of genetic counseling, 2001-08, Vol.10 (4), p.331-341

2001

Volltextzugriff (PDF)

Generations Lost: A Cancer Genetics Case Report

Journal of genetic counseling, 1997-06, Vol.6 (2), p.169-172

Matloff, Ellen T.

1997

Volltextzugriff (PDF)

A clinician's guide to hereditary colon cancer

The cancer journal (Sudbury, Mass.), 2004-09, Vol.10 (5), p.280

2004

Volltextzugriff (PDF)

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

The Lancet (British edition), 2002-04, Vol.27, p.1471-1477

2002

Volltextzugriff (PDF)

Practice variability in prenatal genetic counseling

Journal of genetic counseling, 1994-09, Vol.3 (3), p.215-231

Matloff, Ellen T.

1994

Volltextzugriff (PDF)

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

The New England journal of medicine, 2002-05, Vol.346 (21), p.16-22

2002

Volltextzugriff (PDF)

Conservatively managed breast cancer in young women: outcome as a function of BRCA [formula omitted] status

International journal of radiation oncology, biology, physics, 2000, Vol.48 (3), p.142-142

2000

Volltextzugriff (PDF)

Framework for a proactive parent support group: The syracuse cystic fibrosis model

Journal of pediatric health care, 1996-11, Vol.10 (6), p.264-271

1996

Volltextzugriff (PDF)

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

The women's oncology review, 2004-09, Vol.4 (3), p.241-242

2004

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Englisch
(145)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups

What Would You Do? Specialists’ Perspectives on Cancer Genetic Testing, Prophylactic Surgery, and Insurance Discrimination

Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women

Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

Germline PTEN Promoter Mutations and Deletions in Cowden/Bannayan-Riley-Ruvalcaba Syndrome Result in Aberrant PTEN Protein and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway

Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ

The breast surgeon’s role in BRCA1 and BRCA2 testing

Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history

BRCA1/BRCA2 Germline Mutations in Locally Recurrent Breast Cancer Patients After Lumpectomy and Radiation Therapy: Implications for Breast-Conserving Management in Patients With BRCA1/BRCA2 Mutations

Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer?

Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer

Complex decision-making for BRCA1/2 carriers

Writing Effective Insurance Justification Letters for Cancer Genetic Testing: A Streamlined Approach

Generations Lost: A Cancer Genetics Case Report

A clinician's guide to hereditary colon cancer

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

Practice variability in prenatal genetic counseling

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

Conservatively managed breast cancer in young women: outcome as a function of BRCA [formula omitted] status

Framework for a proactive parent support group: The syracuse cystic fibrosis model

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

Suchergebnisse filtern